Avantium FDCA Plant Faces a Critical Funding Test

Avantium is moving closer to producing its first commercial-scale FDCA in Delfzijl, the Netherlands. However, the renewable-polymers company must complete a substantial financing package while resolving the remaining commissioning issues at its flagship facility.

The oxidation section of the plant has been commissioned, following the start-up of its utilities and sugar-dehydration systems. Work on the purification unit is in its final stages.

If the remaining start-up process and product qualification proceed successfully, Avantium expects to make its first commercial FDCA shipments near the end of 2026. The company’s latest timetable is therefore an objective rather than a guaranteed delivery date.

Key facts

• Avantium held €23.9 million in cash, including restricted cash, on June 30, 2026.
• It intends to raise at least €55 million in equity during 2026.
• A proposed €20 million convertible loan remains conditional on the equity financing.
• First commercial FDCA deliveries are targeted for the fourth quarter of 2026.
• The plant is expected to require 12 to 24 months to reach full capacity.
• Avantium has reported 22 long-term offtake agreements and 15 future-capacity reservations.

Financing becomes the immediate priority

The principal challenge is no longer limited to construction or commissioning. It is also financial.

Avantium’s cash position fell to €23.9 million at the end of June, compared with €57.5 million at the close of 2025. Net cash flow during the first half of 2026 was negative €33.6 million.

To finance plant operations, the production ramp-up and further commercialization, Avantium plans to raise at least €55 million in new equity. It is seeking commitments from shareholders and discussing underwriting arrangements with financial institutions.

The company is also negotiating a proposed €20 million convertible loan with the Investment and Development Agency for the Northern Netherlands, known as NOM. The facility would be supported through the Nij Begun economic-development program.

Importantly, that loan is not yet committed funding. According to Avantium, it remains subject to several conditions, including the successful completion of the planned equity raise.

This dependence makes the equity transaction a central near-term milestone. The combined financing package could provide at least €75 million, but management has not stated that this amount will automatically fund the company through to full plant capacity. Actual requirements will depend partly on future plant revenue and licensing income.

Why the FDCA plant has taken longer to start

The Delfzijl facility was previously expected to complete start-up during the summer of 2026. That schedule slipped after a titanium-welding remediation program and several subsequent commissioning problems.

Management identified equipment issues, insufficient cooling capacity, and the calibration and tuning of instruments among the causes of the latest delays. It said these problems were mechanical and operational rather than evidence of a failure in the underlying chemistry.

That distinction is commercially significant, but it remains a statement from Avantium. Consistent production of purified FDCA will be the more decisive demonstration that the technology works reliably at commercial scale.

The company says only limited additional capital expenditure is required before start-up. Costs associated with the earlier welding work were recorded during the first half of the year, while much of the remaining expenditure is expected to fall under operating costs.  Avantium FDCA plant

Commercial interest is increasing

Avantium’s commercial pipeline provides a more encouraging counterpoint to its financing pressure.

The company has secured 22 long-term agreements covering output from the flagship plant. It has also announced 15 capacity-reservation agreements representing more than 150 kilotonnes of annual FDCA and PEF demand from possible future licensed plants.

That reservation volume increased from approximately 100 kilotonnes at the beginning of 2026. Avantium estimates that the current reservations correspond to a potential annual product value of roughly €750 million.

These figures should be interpreted carefully. Capacity reservations for plants that have not yet been built are indicators of customer interest, not current sales or guaranteed revenue.

Management says it is in advanced discussions with four potential licensees across Europe, North America and Asia. Some partners could be ready to sign agreements during 2027 if the Delfzijl plant demonstrates stable, continuous production at the required quality.

What FDCA and PEF are

FDCA, or furandicarboxylic acid, is the principal chemical building block used to produce polyethylene furanoate, commonly called PEF.

Avantium manufactures FDCA using its YXY process, which converts plant-derived sugars into renewable chemical intermediates. The company markets its PEF under the releaf brand.

PEF is being developed for applications including bottles, films and other packaging formats. Its commercial case depends not only on renewable feedstocks but also on performance, cost, recyclability, regulatory acceptance and the availability of production at industrial scale.

The Delfzijl plant is intended to validate Avantium’s process commercially and provide material to initial customers. Larger-scale growth would depend mainly on licensing the technology to partners capable of constructing substantially bigger production facilities.

A narrower company built around FDCA and PEF

Avantium has reduced spending outside its core polymer business as it attempts to preserve capital.

It sold intellectual property connected with its Ray Technology to UPM, separated its Volta Technology activities into the independent company Carbeau and is preparing a similar separation for Parana Technology. The company has also decided to stop further investment in Dawn Technology.

Its workforce declined to approximately 240 full-time equivalent employees at the end of June, from 284 a year earlier.

The restructuring is intended to concentrate management attention and financial resources on FDCA, PEF and future licensing. It also reflects the pressure visible in the company’s first-half results.

Revenue declined from €6.7 million to €4.7 million, primarily because of weaker activity within Avantium R&D Solutions. EBITDA remained negative at €18.8 million, compared with a loss of €18.5 million in the corresponding 2025 period.

The milestones investors should watch

Avantium now faces three connected tests.

The first is completing the purification unit and producing on-spec FDCA safely. The second is beginning customer deliveries before the end of 2026. The third is securing enough financing to support operations during a gradual production ramp-up.

Management expects the plant to require between 12 and 24 months to reach full capacity, placing that target in the second half of 2028. The company does not believe potential licensees must wait until then. Instead, they are expected to focus on whether the facility can produce purified FDCA continuously and meet its specified process targets.

That evidence could emerge during 2027, but revenue from future licensing agreements remains uncertain in both timing and value.

Avantium has therefore reached a pivotal stage. The company has documented customer interest and has commissioned important sections of its plant. Nevertheless, commercial success now depends on turning that progress into reliable production while completing a financing package under a tight cash position.

Sources and methodology

This article distinguishes reported results from management forecasts and avoids treating proposed financing, capacity reservations or future production as completed outcomes.

Primary information was checked against Avantium’s first-half 2026 company update and its August 2026 analyst-call transcript. Recent reporting published within the requested three-day window was also reviewed through Indian Chemical News.

Avantium FDCA Plant Advances Toward Start-Up